108 related articles for article (PubMed ID: 9627225)
1. EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurements.
Nagy P; Bene L; Balázs M; Hyun WC; Lockett SJ; Chiang NY; Waldman F; Feuerstein BG; Damjanovich S; Szöllosi J
Cytometry; 1998 Jun; 32(2):120-31. PubMed ID: 9627225
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
4. Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.
Wosikowski K; Schuurhuis D; Johnson K; Paull KD; Myers TG; Weinstein JN; Bates SE
J Natl Cancer Inst; 1997 Oct; 89(20):1505-15. PubMed ID: 9337347
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
6. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.
Nagy P; Vereb G; Sebestyén Z; Horváth G; Lockett SJ; Damjanovich S; Park JW; Jovin TM; Szöllosi J
J Cell Sci; 2002 Nov; 115(Pt 22):4251-62. PubMed ID: 12376557
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric FRET analysis of ErbB receptor tyrosine kinase interaction.
Diermeier-Daucher S; Brockhoff G
Curr Protoc Cytom; 2008 Jul; Chapter 12():Unit12.14. PubMed ID: 18770646
[TBL] [Abstract][Full Text] [Related]
8. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation.
Wang Z; Zhang L; Yeung TK; Chen X
Mol Biol Cell; 1999 May; 10(5):1621-36. PubMed ID: 10233167
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal expression of epidermal growth factor receptor (EGF-R) and c-erbB2 by non-invasive and invasive human trophoblast populations.
Jokhi PP; King A; Loke YW
Cytokine; 1994 Jul; 6(4):433-42. PubMed ID: 7948752
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric FRET analysis of erbB receptor interaction on a cell-by-cell basis.
Diermeier-Daucher S; Hasmann M; Brockhoff G
Ann N Y Acad Sci; 2008; 1130():280-6. PubMed ID: 18596360
[TBL] [Abstract][Full Text] [Related]
11. EGFR and ErbB2 differentially regulate Raf-1 translocation and activation.
Zhang L; Bewick M; Lafrenie RM
Lab Invest; 2002 Jan; 82(1):71-8. PubMed ID: 11796827
[TBL] [Abstract][Full Text] [Related]
12. Modular anti-EGFR and anti-Her2 targeting of SK-BR-3 and BT474 breast cancer cell lines in the presence of ErbB receptor-specific growth factors.
Diermeier-Daucher S; Breindl S; Buchholz S; Ortmann O; Brockhoff G
Cytometry A; 2011 Sep; 79(9):684-93. PubMed ID: 21786419
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
[TBL] [Abstract][Full Text] [Related]
14. Two-sided fluorescence resonance energy transfer for assessing molecular interactions of up to three distinct species in confocal microscopy.
Fazekas Z; Petrás M; Fábián A; Pályi-Krekk Z; Nagy P; Damjanovich S; Vereb G; Szöllosi J
Cytometry A; 2008 Mar; 73(3):209-19. PubMed ID: 18044751
[TBL] [Abstract][Full Text] [Related]
15. Cell death induced by TNF or serum starvation is independent of ErbB receptor signaling in MCF-7 breast carcinoma cells.
Egeblad M; Jäättelä M
Int J Cancer; 2000 Jun; 86(5):617-25. PubMed ID: 10797281
[TBL] [Abstract][Full Text] [Related]
16. Insulin and epidermal growth factor stimulate phosphorylation of p185HER-2 in the breast carcinoma cell line, BT474.
Lin YZ; Li SW; Clinton GM
Mol Cell Endocrinol; 1990 Mar; 69(2-3):111-9. PubMed ID: 1691719
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: local stimulation using magnetic microspheres as assessed by quantitative digital microscopy.
Friedländer E; Arndt-Jovin DJ; Nagy P; Jovin TM; Szöllosi J; Vereb G
Cytometry A; 2005 Oct; 67(2):161-71. PubMed ID: 16163699
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
Li CC; Yao HT; Cheng FJ; Hsieh YH; Lu CY; Wu CC; Liu KL; Chang JW
Nutr Cancer; 2015; 67(5):771-82. PubMed ID: 25970488
[TBL] [Abstract][Full Text] [Related]
19. Cetuximab enhances the anti-proliferative effect of trastuzumab in ERBB2 over-expressing breast cancer cells--preliminary study.
Uberall I; Krízová K; Steigerová J
Klin Onkol; 2011; 24(5):356-60. PubMed ID: 22070017
[TBL] [Abstract][Full Text] [Related]
20. Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells.
Daly JM; Jannot CB; Beerli RR; Graus-Porta D; Maurer FG; Hynes NE
Cancer Res; 1997 Sep; 57(17):3804-11. PubMed ID: 9288791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]